Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Boehringer Appoints President of U.S. Fremont Biopharma Biz | Contract Pharma
Breaking News, Promotions & Moves

Boehringer Appoints President of U.S. Fremont Biopharma Biz

Lars Dreesmann will lead the biopharmaceuticals development and manufacturing business.

Boehringer Ingelheim has appointed Lars Dreesmann, Ph.D., as President of the company’s U.S. biopharmaceutical development and manufacturing business, Boehringer Ingelheim Fremont, Inc. Most recently, Dr. Dreesmann was Head of Global Quality Systems & Product Compliance Biopharma for Boehringer Ingelheim, a role he has held since January 2019. In his new role, Dr. Dreesmann will report to Jean-Michel Boers, U.S. Country Managing Director, President & CEO, Boehringer Ingelheim.

Since joining the company in 2001, Dr. Dreesmann has held a series of leadership roles with increasing levels of responsibility within the company’s Biopharmaceuticals headquarters in Germany. His research has been published in multiple scientific and medical journals and he holds a patent in the field of neurobiology.

“We are extremely pleased to have Lars take on the leadership of our US biopharmaceuticals business during this critical time of growth,” said Jean-Michel Boers, US Country Managing Director, President & CEO, Boehringer Ingelheim. “He is a proven leader with a keen scientific mind and a deep understanding of our business, which he gained during his more than a dozen years in Boehringer Ingelheim’s global Biopharmaceuticals headquarters. We wish Lars much success in his new role.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters